Department of Preventive Medicine & Biostatistics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814-4799.
Departments of Oncology and Biochemistry & Molecular and Cellular Biology, Georgetown University, E411 New Research Building, Washington, DC 20057.
Mil Med. 2020 Dec 30;185(11-12):e2088-e2096. doi: 10.1093/milmed/usaa176.
The U.S. Preventive Services Task Force (USPSTF) modified their screening guidelines for breast cancer in November 2009. Previous studies evaluated the impact of these guideline changes among privately and Medicare insured populations. Women in the military form a unique population exposed to many social, environmental, and occupational hazards that may increase breast cancer incidence. By evaluating mammography screening rates among women in the military before and after the USPSTF guideline changes, this study evaluated the impact of the USPSTF breast cancer guideline change on screening mammography use within the military population and determined whether current guidelines were followed for this high-risk population with universal health care access.
This study evaluated the impact of the 2009 guideline changes among the population of universally insured military servicewomen, comparing the proportion of active duty women aged 40 to 64 receiving mammograms from fiscal years 2006 to 2015 using an interrupted time series analysis. Stratified analyses evaluated differences by age (aged 40-49, 50-64), race, military branch, and rank. This research is considered exempt by the Uniformed Services University Institutional Review Board.
The proportion of insured military servicewomen receiving mammograms increased from October 2005 through September 2009. A significant decrease occurred in the first quarter of 2010 following the publication of the screening guideline update. From this new baseline, the proportion of women screened increased again through September 2015. Comparative analyses showed more pronounced effects both immediately and over time among the women aged 50 to 64 compared to those aged 40 to 49 years and among older enlisted women compared with their officer counterparts. The patterns were near identical in all subgroups; however, no changes in rate were evident among Air Force and black servicewomen aged 50 to 64 and Army and Navy/Marine Corps servicewomen aged 40 to 49 years. No racial disparities in screening or impact were noted.
The USPSTF guidelines had differential impacts among some subpopulations. While older women, aged 50 to 64 years, had a greater temporary reduction immediately after the guideline change, younger women aged 40 to 49 years had a longer-term reduction in screening following the guideline changes. No racial disparities in the proportion screened or in the impact of the guideline change were noted in this population with universal health coverage. The lack of Department of Defense standard breast cancer screening guidelines was evident from the different patterns of mammography utilization observed among military branches. To completely understand the impact of the updated screening guidelines, future studies must incorporate research focusing on changes in breast cancer morbidity and mortality as well as updated cost-benefit analyses.
美国预防服务工作组(USPSTF)于 2009 年 11 月修改了其乳腺癌筛查指南。先前的研究评估了这些指南变更对私人保险和医疗保险参保人群的影响。军人是一个独特的群体,他们面临着许多社会、环境和职业危害,这些危害可能会增加乳腺癌的发病率。通过评估 USPSTF 指南变更前后军人中妇女的乳房 X 光筛查率,本研究评估了 USPSTF 乳腺癌指南变更对军人人群中筛查性乳房 X 光检查使用的影响,并确定了在普遍获得医疗保健的情况下,是否遵循了这些高危人群的现行指南。
本研究评估了 2009 年指南变更对普遍受保的现役女兵人群的影响,比较了 2006 财年至 2015 财年期间,40 至 64 岁的现役女性接受乳房 X 光检查的比例,使用中断时间序列分析。分层分析按年龄(40-49 岁、50-64 岁)、种族、军种和军衔评估差异。这项研究被统一服务大学机构审查委员会视为豁免。
接受乳房 X 光检查的受保军人女性比例从 2005 年 10 月至 2009 年 9 月增加。2010 年第一季度,在发布筛查指南更新后,这一比例出现显著下降。从这个新的基线开始,女性筛查比例又再次增加,直到 2015 年 9 月。比较分析显示,与 40 至 49 岁的女性相比,50 至 64 岁的女性以及年长的入伍女性与军官相比,立即和长期的影响更为明显。所有亚组都呈现出相似的模式;然而,50 至 64 岁的空军和黑人女性以及 40 至 49 岁的陆军和海军/海军陆战队女性的筛查率没有变化。没有发现筛查或影响方面的种族差异。
USPSTF 指南对一些亚人群有不同的影响。虽然年龄较大的 50 至 64 岁女性在指南变更后立即出现了更大的暂时性减少,但年龄较小的 40 至 49 岁女性在指南变更后则长期减少了筛查。在这个普遍享有医疗保险的人群中,没有注意到筛查比例或指南变更影响方面的种族差异。从观察到的军事部门中乳房 X 光利用率的不同模式可以看出,国防部缺乏标准的乳腺癌筛查指南。为了全面了解更新后的筛查指南的影响,未来的研究必须纳入关注乳腺癌发病率和死亡率变化以及更新的成本效益分析的研究。